Over the past few years the ever changing market of Bioinformatics applications have acquired wide acceptance owing to decline in the manufacture of new drugs, absence of potential drugs and expiry of patents. This market with revenue of $1.4 billion in 2004-05, has been competing with other Bioinformatics companies, facilitating R&D for the unusual and innovative tools critical to its success.
As per the recent market research report "World Bioinformatics Market [2005-2010" published by RNCOS, the global market for nanotechnology in Bioinformatics applications is expected to exceed $900 million in 2005 and about $3.5 billion by 2010, increasing at an average annual growth rate of approximately 31%. The report also forecasts Agro-technology to increase its share from 5.1% to 13.4% by 2010.
The convergence of biotechnology, nanotechnology and computing has forged a way for mergers between industries. The future may see an alliance between pharmaceutical and nanotechnology or computing firms, in areas of research and IT capabilities. There maybe alliances between pharmaceutical, software and very strong marketing firms. This field could very soon witness the entry of computing and telecommunication firms also.
To purchase your copy: http://www.rncos.com/Report/Biotech013.htm
For more information about the report please visit www.rncos.com
Tags: mergers, marketing firms, alliances, global market, food products, dressings, convergence, expiry, new drugs, innovative tools, packaging materials
This article is free for republishing
Source: http://www.articlealley.com/article_44820_15.html
Source: http://www.articlealley.com/article_44820_15.html
